Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Study to Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)

ClinicalTrials.gov ID: NCT04488133

Public ClinicalTrials.gov record NCT04488133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Study of Nusinersen (BIIB058) Among Patients With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec

Study identification

NCT ID
NCT04488133
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Biogen
Industry
Enrollment
46 participants

Conditions and interventions

Interventions

  • Nusinersen Drug

Drug

Eligibility (public fields only)

Age range
2 Months to 36 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 3, 2021
Primary completion
Oct 8, 2025
Completion
Oct 8, 2025
Last update posted
Oct 13, 2025

2021 – 2025

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
Arkansas Children's Hospital Research Institute Little Rock Arkansas 72202
Stanford Neuromuscular Research Palo Alto California 94304
Children's Hospital Colorado Aurora Colorado 80045
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
Massachusetts General Hospital Boston Massachusetts 02114
Oregon Health and Science University (OHSU) Portland Oregon 97239
Children's Hospital Philadelphia - Neurology Philadelphia Pennsylvania 19104
University of Utah Salt Lake City Utah 84112
Children's Hospital of The King's Daughters Norfolk Virginia 23510

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04488133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04488133 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →